Palvella presents Phase 2 data on bleeding reduction treatment
Corroborated by 2 sources from 2 publishers
globalcrime6h ago
TL;DR
May.
Sources
1
Business Insider Markets News
https://markets.businessinsider.com/news/stocks/palvella-therapeutics-announces-new-data-from-the-phase-2-toiva-trial-of-qtorin-rapamycin-in-cutaneous-venous-malformations-presented-at-the-83rd-annual-meeting-of-the-society-for-investigative-1036163178
6h ago
2
Investing.com News
https://www.investing.com/news/company-news/palvella-presents-phase-2-data-on-bleeding-reduction-treatment-93CH-4692015
6h ago